SG11201400260TA - Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration - Google Patents
Method for preparing a composition comprising highly concentrated antibodies by ultrafiltrationInfo
- Publication number
- SG11201400260TA SG11201400260TA SG11201400260TA SG11201400260TA SG11201400260TA SG 11201400260T A SG11201400260T A SG 11201400260TA SG 11201400260T A SG11201400260T A SG 11201400260TA SG 11201400260T A SG11201400260T A SG 11201400260TA SG 11201400260T A SG11201400260T A SG 11201400260TA
- Authority
- SG
- Singapore
- Prior art keywords
- ultrafiltration
- preparing
- composition
- highly concentrated
- concentrated antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/22—Controlling or regulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/14—Pressure control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/16—Flow or flux control
- B01D2311/165—Cross-flow velocity control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/14—Batch-systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2321/00—Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
- B01D2321/02—Forward flushing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161530158P | 2011-09-01 | 2011-09-01 | |
| PCT/JP2012/005536 WO2013031237A1 (en) | 2011-09-01 | 2012-08-31 | Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201400260TA true SG11201400260TA (en) | 2014-03-28 |
Family
ID=46982845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400260TA SG11201400260TA (en) | 2011-09-01 | 2012-08-31 | Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9630988B2 (pt) |
| EP (2) | EP2750784A1 (pt) |
| JP (2) | JP6363017B2 (pt) |
| KR (1) | KR101993488B1 (pt) |
| CN (1) | CN103889555B (pt) |
| AU (2) | AU2012303372A1 (pt) |
| BR (1) | BR112014004828B8 (pt) |
| CA (1) | CA2847302C (pt) |
| IL (1) | IL231128B (pt) |
| MX (1) | MX359235B (pt) |
| MY (1) | MY182178A (pt) |
| RU (1) | RU2638859C9 (pt) |
| SG (1) | SG11201400260TA (pt) |
| WO (1) | WO2013031237A1 (pt) |
| ZA (1) | ZA201401184B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2312184T3 (es) | 1997-03-21 | 2009-02-16 | Chugai Seiyaku Kabushiki Kaisha | Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas. |
| UA80091C2 (en) | 2001-04-02 | 2007-08-27 | Chugai Pharmaceutical Co Ltd | Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist |
| GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
| PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
| DK2493922T3 (en) | 2009-10-26 | 2017-04-24 | Hoffmann La Roche | Process for preparing a glycosylated immunoglobulin |
| CN103476793A (zh) | 2010-11-08 | 2013-12-25 | 基因技术公司 | 皮下施用的抗-il-6受体抗体 |
| JP6062433B2 (ja) * | 2011-08-03 | 2017-01-18 | プロラクタ バイオサイエンス，インコーポレイテッド | 細菌汚染を低減するためのヒト乳の精密濾過 |
| BR112015032960B1 (pt) | 2013-07-04 | 2021-01-05 | F. Hoffmann-La Roche Ag | imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro |
| WO2016067177A1 (en) | 2014-10-27 | 2016-05-06 | Tmci Padovan S.P.A. | Improved filtration plant and relative method |
| CN104673666A (zh) * | 2015-03-10 | 2015-06-03 | 华东理工大学 | 一种微型切向流过滤模拟装置 |
| GB201600287D0 (en) * | 2016-01-07 | 2016-02-24 | Fujifilm Diosynth Biotechnologies Uk Ltd | Process |
| IL264907B2 (en) | 2016-09-15 | 2023-03-01 | Evoqua Water Tech Llc | Method and system for treating ultra-purified water |
| JP6399723B1 (ja) * | 2018-02-21 | 2018-10-03 | 株式会社グロータック | 自転車用変速操作装置 |
| US11446326B2 (en) | 2018-07-27 | 2022-09-20 | ARC Medical Devices | Highly sulfated fucans for the treatment of fibrous adhesions |
| CN112566920A (zh) * | 2018-08-14 | 2021-03-26 | 百时美施贵宝公司 | 改善的蛋白质回收 |
| DE102019101745A1 (de) * | 2019-01-24 | 2020-07-30 | Putsch Gmbh & Co. Kg | Verfahren zum Betrieb einer Membranfilteranlage |
| JP7135257B2 (ja) * | 2019-03-05 | 2022-09-13 | エーアールシー メディカル デバイス，インク． | 粘性組成物のタンジェンシャルフローろ過のためのシステム及び方法 |
| CN111018968B (zh) * | 2019-12-16 | 2021-07-27 | 兴盟生物医药(苏州)有限公司 | 一种通过超滤浓缩制备高浓度抗体制剂的方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6443305A (en) * | 1987-08-10 | 1989-02-15 | Fuji Photo Film Co Ltd | Cross flow type filtration process |
| CA2021165A1 (en) | 1989-07-14 | 1991-01-15 | Henry N. Beck | Isotropic or anisotropic microporous syndiotactic polystyrene membranes and processes for preparation |
| JPH0380921A (ja) * | 1989-08-24 | 1991-04-05 | Shinko Pantec Co Ltd | 膜濾過装置の運転方法 |
| JPH0778025B2 (ja) | 1990-03-20 | 1995-08-23 | 日本赤十字社 | 免疫グロブリンｇの製造方法 |
| WO1992019759A1 (en) | 1991-04-25 | 1992-11-12 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
| JP3091885B2 (ja) | 1991-07-05 | 2000-09-25 | 株式会社日立製作所 | 高温型二次電池及び電池モジュール |
| US6903194B1 (en) | 1996-09-26 | 2005-06-07 | Chungai Seiyaku Kabushiki Kaisha | Antibody against human parathormone related peptides |
| UA76934C2 (en) | 1996-10-04 | 2006-10-16 | Chugai Pharmaceutical Co Ltd | Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody |
| NZ335203A (en) * | 1996-10-10 | 2000-10-27 | Neose Technologies Inc | Carbohydrate, purification using ultrafiltration, reverse osmosis and nanofiltration |
| CH692479A5 (de) * | 1997-07-08 | 2002-07-15 | Bucher Guyer Ag | Querstrom-Filtrationsanlage sowie Verfahren zum Betrieb einer solchen Anlage. |
| US6096872A (en) * | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
| HUP0101160A2 (hu) | 1998-04-03 | 2001-08-28 | Chugai Seiyaku Kabushiki Kaisha | Humán szöveti faktor (TF) elleni humanizált antitest és eljárás előállítására |
| DE19827473C1 (de) | 1998-06-19 | 1999-08-26 | Sartorius Gmbh | Verbesserte Crossflow-Filterkassetten |
| TWI241345B (en) | 2000-03-10 | 2005-10-11 | Chugai Pharmaceutical Co Ltd | Apoptosis inducing polypeptide |
| US6350382B1 (en) * | 2000-06-23 | 2002-02-26 | Scilog, Inc. | Enhancing filtration yields in tangential flow filtration |
| DE60139944D1 (de) | 2000-10-12 | 2009-10-29 | Genentech Inc | Niederviskose konzentrierte proteinformulierungen |
| WO2002033072A1 (en) | 2000-10-20 | 2002-04-25 | Chugai Seiyaku Kabushiki Kaisha | Degraded tpo agonist antibody |
| US20030013172A1 (en) * | 2001-05-14 | 2003-01-16 | Joel Gerendash | Novel methods of enzyme purification |
| NZ537687A (en) * | 2002-06-21 | 2008-04-30 | Biogen Idec Inc | Buffered formulations for concentrating antibodies and methods of use thereof |
| CA2516836A1 (en) | 2003-02-24 | 2004-09-10 | Gtc Biotherapeutics, Inc. | Methods of tangential flow filtration and an apparatus therefore |
| DE602004030451D1 (de) | 2003-07-15 | 2011-01-20 | Chugai Pharmaceutical Co Ltd | Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion |
| JP4439526B2 (ja) | 2004-02-18 | 2010-03-24 | ブーハー−グイアー・アクチェンゲゼルシャフト | 製品を完全濾過する方法とこの方法を実施する装置 |
| US7410587B2 (en) | 2004-08-03 | 2008-08-12 | Scilog, Inc. | Liquid handling for filtration and preparative chromatography |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| DOP2006000029A (es) * | 2005-02-07 | 2006-08-15 | Genentech Inc | Antibody variants and uses thereof. (variantes de un anticuerpo y usos de las mismas) |
| JP5099930B2 (ja) | 2007-06-19 | 2012-12-19 | 旭化成株式会社 | 免疫グロブリン１量体の分離方法 |
| US8741600B2 (en) | 2007-06-19 | 2014-06-03 | Asahi Kasei Kabushiki Kaisha | Method for separation of immunoglobulin monomers |
| EP2236604B1 (en) | 2007-12-05 | 2016-07-06 | Chugai Seiyaku Kabushiki Kaisha | Anti-nr10 antibody and use thereof |
| PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
| BRPI0911994A2 (pt) * | 2008-05-15 | 2015-10-20 | Health L P W | processo para a produção de uma fração de leite enriquecida com iga secretora, produto, e, composição. |
| JP2010047527A (ja) * | 2008-08-22 | 2010-03-04 | Asahi Kasei Corp | 免疫グロブリン１量体の分離方法 |
| JP6159528B2 (ja) * | 2009-03-24 | 2017-07-05 | ワイス・エルエルシー | 高濃縮のタンパク質治療薬を生成するための膜蒸発 |
| JP2010248092A (ja) * | 2009-04-13 | 2010-11-04 | Asahi Kasei Corp | 免疫グロブリン１量体の分離方法 |
| TWI609698B (zh) | 2010-01-20 | 2018-01-01 | Chugai Pharmaceutical Co Ltd | 穩定化的含抗體溶液製劑 |
-
2012
- 2012-08-31 MY MYPI2014700440A patent/MY182178A/en unknown
- 2012-08-31 RU RU2014112230A patent/RU2638859C9/ru active
- 2012-08-31 EP EP12769502.1A patent/EP2750784A1/en not_active Ceased
- 2012-08-31 US US14/241,567 patent/US9630988B2/en active Active
- 2012-08-31 AU AU2012303372A patent/AU2012303372A1/en not_active Abandoned
- 2012-08-31 KR KR1020147008464A patent/KR101993488B1/ko active IP Right Grant
- 2012-08-31 CA CA2847302A patent/CA2847302C/en active Active
- 2012-08-31 BR BR112014004828A patent/BR112014004828B8/pt active IP Right Grant
- 2012-08-31 CN CN201280053636.1A patent/CN103889555B/zh active Active
- 2012-08-31 EP EP17170961.1A patent/EP3235557A1/en active Pending
- 2012-08-31 WO PCT/JP2012/005536 patent/WO2013031237A1/en active Application Filing
- 2012-08-31 JP JP2014510575A patent/JP6363017B2/ja active Active
- 2012-08-31 MX MX2014002253A patent/MX359235B/es active IP Right Grant
- 2012-08-31 SG SG11201400260TA patent/SG11201400260TA/en unknown
-
2014
- 2014-02-17 ZA ZA2014/01184A patent/ZA201401184B/en unknown
- 2014-02-24 IL IL231128A patent/IL231128B/en active IP Right Grant
-
2017
- 2017-03-06 JP JP2017041820A patent/JP6363751B2/ja active Active
- 2017-03-17 US US15/461,874 patent/US10590164B2/en active Active
- 2017-06-28 AU AU2017204395A patent/AU2017204395B2/en active Active
-
2020
- 2020-02-05 US US16/782,493 patent/US20200172569A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL231128B (en) | A method for preparing a preparation containing highly concentrated antibodies using ultrafiltration | |
| IL263389B (en) | A method for the production of modified 5-fluoro-1h-pyrazolopyridines | |
| ZA201402205B (en) | Process for preparing a food composition | |
| EP2773661A4 (en) | PROCESS FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES | |
| SG11201403044VA (en) | Method for preparing surfaces | |
| EP2562152A4 (en) | PROCESS FOR PREPARING 2,5-DIMETHYLPHENYL-ACETIC ACID | |
| EP2687588A4 (en) | PROCESS FOR THE PRODUCTION OF BIODIESEL | |
| EP2700636A4 (en) | PROCESS FOR THE PREPARATION OF EPISULPHIDE COMPOUNDS | |
| IL227872A0 (en) | A process for the preparation of n-converted phenylhydroxylamines | |
| IL260947B (en) | Methods for preparing an immunoglobulin preparation | |
| EP2671864A4 (en) | PROCESS FOR PRODUCING XYLYLENEDIAMINE | |
| EP2725033A4 (en) | METHOD FOR PRODUCING A PROTEIN PREPARATION | |
| EP2679569A4 (en) | METHOD FOR PRODUCING A MONOTERTY GLYCOL BUTYL ETHER COMPOUND | |
| EP2703386A4 (en) | METHOD FOR PRODUCING A DIAMIN COMPOUND | |
| EP2671865A4 (en) | METHOD OF MANUFACTURING AN AMINO BINDING | |
| EP2687505A4 (en) | PROCESS FOR PREPARING A DINITRILE COMPOUND | |
| EP2754664A4 (en) | PROCESS FOR THE PREPARATION OF TRIALKOXYSILANE | |
| EP2789690A4 (en) | PROCESS FOR PRODUCING A PLANT WITH REDUCED FRUITABILITY | |
| EP2752402A4 (en) | METHOD OF PREPARING A 2-ALKENYLAMINE COMPOUND | |
| IL232630A0 (en) | A method for the preparation of 6,2-difluoroacetophenones | |
| IL228851A0 (en) | A method for preparing a concentrate of factor xi | |
| HK1199446A1 (en) | Method for preparing cyclopropane derivatives | |
| EP2752401A4 (en) | PROCESS FOR PRODUCING 2-ALKENYLAMINE COMPOUND | |
| GB201112725D0 (en) | Process for preparing composite membranes | |
| IL229392A0 (en) | A method for producing an isoxazoline compound |